Pages that link to "Q44539384"
Jump to navigation
Jump to search
The following pages link to In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy. (Q44539384):
Displaying 28 items.
- Molecular imaging and therapy targeting copper metabolism in hepatocellular carcinoma (Q26772332) (← links)
- Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability (Q27339846) (← links)
- PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog. (Q30766002) (← links)
- Phage display in molecular imaging and diagnosis of cancer (Q33532734) (← links)
- Synthesis and biodistribution of oligonucleotide-functionalized, tumor-targetable carbon nanotubes. (Q33762411) (← links)
- Complementary optical and nuclear imaging of caspase-3 activity using combined activatable and radio-labeled multimodality molecular probe (Q34043927) (← links)
- Pretargeted radioimmunotherapy for hematologic and other malignancies (Q34113941) (← links)
- Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinoma (Q35059542) (← links)
- Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor (Q35063676) (← links)
- Harnessing the bioorthogonal inverse electron demand Diels-Alder cycloaddition for pretargeted PET imaging (Q35162177) (← links)
- Recent trends in antibody-based oncologic imaging (Q35643425) (← links)
- Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomas (Q35828820) (← links)
- Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomas (Q35849837) (← links)
- Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics. (Q36418274) (← links)
- SPECT/NIRF Dual Modality Imaging for Detection of Intraperitoneal Colon Tumor with an Avidin/Biotin Pretargeting System (Q36432456) (← links)
- Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography (Q36647876) (← links)
- A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies (Q36908712) (← links)
- Roles of Atox1 and p53 in the trafficking of copper-64 to tumor cell nuclei: implications for cancer therapy (Q37632783) (← links)
- Pretargeted molecular imaging and radioimmunotherapy (Q38022016) (← links)
- Reduced 64Cu uptake and tumor growth inhibition by knockdown of human copper transporter 1 in xenograft mouse model of prostate cancer. (Q39014453) (← links)
- A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry. (Q39147376) (← links)
- VPAC1 Targeted 64Cu-TP3805 kit preparation and its evaluation. (Q40475702) (← links)
- A New Highly Reactive and Low Lipophilicity Fluorine-18 Labeled Tetrazine Derivative for Pretargeted PET Imaging. (Q43083925) (← links)
- A comparison of PET imaging characteristics of various copper radioisotopes (Q46782391) (← links)
- Anticancer Activity of Copper Complex of (4R)-(-)-2-Thioxo-4-thiazolidinecarboxylic Acid and 3-Rhodaninepropionic Acid on Prostate and Breast Cancer Cells by Fluorescent Microscopic Imaging. (Q47827072) (← links)
- Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT. (Q48554795) (← links)
- Evaluation of a Pretargeting Strategy for Molecular Imaging of the Prostate Stem Cell Antigen with a Single Chain Antibody. (Q55246887) (← links)
- Therapeutic Applications of Pretargeting (Q93079994) (← links)